Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

Literature DB >> 30855754

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

Burak Y Aktas¹, Hakan Taban¹, Sercan Aksoy¹.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2019 PMID： 30855754 DOI： 10.1056/NEJMc1900150

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

6 in total

1. Unexpected PD-L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodies.

Authors: Tanmoy Mondal; Gururaj N Shivange; Rachisan Gt Tihagam; Evan Lyerly; Michael Battista; Divpriya Talwar; Roxanna Mosavian; Karol Urbanek; Narmeen S Rashid; J Chuck Harrell; Paula D Bos; Edward B Stelow; M Sharon Stack; Sanchita Bhatnagar; Jogender Tushir-Singh
Journal: EMBO Mol Med Date: 2021-02-15 Impact factor: 12.137

2. FUT8-mediated aberrant N-glycosylation of B7H3 suppresses the immune response in triple-negative breast cancer.

Authors: Yun Huang; Hai-Liang Zhang; Zhi-Ling Li; Tian Du; Yu-Hong Chen; Yan Wang; Huan-He Ni; Kai-Ming Zhang; Jia Mai; Bing-Xin Hu; Jun-Hao Huang; Li-Huan Zhou; Dong Yang; Xiao-Dan Peng; Gong-Kan Feng; Jun Tang; Xiao-Feng Zhu; Rong Deng
Journal: Nat Commun Date: 2021-05-11 Impact factor: 14.919

Review 3. Inflammation Is Associated with Worse Outcome in the Whole Cohort but with Better Outcome in Triple-Negative Subtype of Breast Cancer Patients.

Authors: Masanori Oshi; Stephanie Newman; Yoshihisa Tokumaru; Li Yan; Ryusei Matsuyama; Itaru Endo; Kazuaki Takabe
Journal: J Immunol Res Date: 2020-12-08 Impact factor: 4.818

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.

1. Unexpected PD-L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodies.

2. FUT8-mediated aberrant N-glycosylation of B7H3 suppresses the immune response in triple-negative breast cancer.

Review 3. Inflammation Is Associated with Worse Outcome in the Whole Cohort but with Better Outcome in Triple-Negative Subtype of Breast Cancer Patients.

4. The global status of research in breast cancer liver metastasis: a bibliometric and visualized analysis.

5. Immunoarchitectural patterns as potential prognostic factors for invasive ductal breast cancer.

6. The E2F Pathway Score as a Predictive Biomarker of Response to Neoadjuvant Therapy in ER+/HER2- Breast Cancer.